CollPlant Biotechnologies Ltd. (CLGN) has a market capitalization of $4.18M and trades at $0.34. The 52-week range is 0.495-4.98.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-0.94, annual revenue of $2.37M.
The stock has a beta of 0.94, operates in the Healthcare sector.
